CSL Share Price

Open 131.06 Change Price %
High 131.10 1 Day -0.79 -0.60
Low 129.39 1 Week -4.04 -3.01
Close 130.27 1 Month 1.85 1.44
Volume 630121 1 Year 16.40 14.40
52 Week High 136.85
52 Week Low 91.62
CSL Important Levels
Resistance 2 131.86
Resistance 1 131.20
Pivot 130.25
Support 1 129.34
Support 2 128.68
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
FXJ 1.25 0.00%
TLS 4.49 1.35%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
BNV 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
ESI 0.01 -50.00%
ESI 0.01 -50.00%
ESI 0.01 -50.00%
ESI 0.01 -50.00%
ESI 0.01 -50.00%
More..

CSL Ltd (ASX: CSL)

CSL Technical Analysis 4
As on 22nd May 2017 CSL Share Price closed @ 130.27 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 111.99 & Buy for SHORT-TERM with Stoploss of 127.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
CSL Target for May
1st Target up-side 137.17
2nd Target up-side 140.41
3rd Target up-side 143.65
1st Target down-side 127.93
2nd Target down-side 124.69
3rd Target down-side 121.45
CSL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.csl.com.au
CSL Address
CSL
45 Poplar Road
Parkville, VIC 3052
Australia
Phone: 61 3 9389 1911
Fax: 61 3 9389 1434
CSL Latest News
At $135 per share, is CSL Limited still an opportunity?   Motley Fool Australia   - 12th May 17
CSL Limited (ASX:CSL) Stock Overbought   Live Trading News   - 27th Apr 17
How CSL Limited makes most of its money   Motley Fool Australia   - 18th Apr 17
2 growth shares to buy instead of CSL Limited   Motley Fool Australia   - 04th Apr 17
Are CSL Limited (ASX:CSL) shares overpriced today?   Motley Fool Australia   - 13th Mar 17
Where to next for the CSL Limited share price?   Motley Fool Australia   - 15th Feb 17
Are CSL Limited shares still a buy after its profit upgrade?   Motley Fool Australia   - 25th Jan 17
Why CSL Limited shares could fly on its profit upgrade   Motley Fool Australia   - 19th Jan 17
Is CSL Limited a buy at this share price?   Motley Fool Australia   - 09th Jan 17
Why the CSL Limited share price plunged today   Motley Fool Australia   - 17th Aug 16
Interactive Technical Analysis Chart CSL Ltd ( CSL ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CSL Ltd
CSL Business Profile
CSL Limited engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Switzerland, Germany, and internationally. The company operates through CSL Behring, bioCSL, and CSL Intellectual Property segments. The CSL Behring segment manufactures, markets, and develops plasma therapies, including plasma products and recombinants that are used to treat coagulation disorders, including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders, cardiac surgery, organ transplantation, and burn treatment, as well as to prevent hemolytic diseases in the newborn. The bioCSL segment manufactures and distributes non-plasma biotherapeutic products, including biological products for human use; vaccines to prevent viral and bacterial diseases; prescription pharmaceuticals to treat a range of human medical conditions; in vitro diagnostic products; and antivenoms to treat victims of venomous snake and spider bites. The CSL Intellectual Property segment engages in the commercialization of intellectual property. In addition, the company markets various vaccines and antivenoms, as well as a range of pharmaceutical products supplied by other manufacturers. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.